Virtus Biotech ETF (BBP)

Assets	$58.45M
Expense Ratio	0.34%
PE Ratio	n/a
Shares Out	700,004
Dividend (ttm)	n/a
Dividend Yield	n/a
Ex-Dividend Date	n/a
Payout Frequency	n/a
Payout Ratio	n/a

Volume	190
Open	84.76
Previous Close	84.78
Day's Range	84.60 - 84.79
52-Week Low	n/a
52-Week High	n/a
Beta	0.58
Holdings	63
Inception Date	Dec 17, 2014

About BBP

Fund Home Page

The Virtus Biotech ETF (BBP) is an exchange-traded fund that is based on the LifeSci Biotechnology Products index. The fund tracks an index of US-listed biotechnology companies considered to be in the product stage by the index provider. BBP was launched on Dec 17, 2014 and is issued by Virtus Investment Partners.

• Asset Class: Equity
• Category: Health
• Region: North America
• Stock Exchange: NYSEARCA
• Ticker Symbol: BBP
• ETF Provider: Virtus Investment Partners
• Index Tracked: LifeSci Biotechnology Products Index

Top 10 Holdings

25.33% of assets

Name	Symbol	Weight
ImmunityBio, Inc.	IBRX	4.78%
Apellis Pharmaceuticals, Inc.	APLS	2.63%
KalVista Pharmaceuticals, Inc.	KALV	2.56%
Moderna, Inc.	MRNA	2.52%
Iovance Biotherapeutics, Inc.	IOVA	2.44%
Mirum Pharmaceuticals, Inc.	MIRM	2.35%
Kiniksa Pharmaceuticals International, plc	KNSA	2.07%
Roivant Sciences Ltd.	ROIV	2.02%
Axsome Therapeutics, Inc.	AXSM	2.01%
Novavax, Inc.	NVAX	1.97%

Performance

BBP had a total return of 46.37% in the past year, including dividends. Since the fund's inception, the average annual return has been 10.95%.